SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-029472
Filing Date
2017-05-02
Accepted
2017-05-02 21:04:01
Documents
2
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4307
2 POA DOCUMENT poa.txt EX-24.4_720803 4008
  Complete submission text file 0001209191-17-029472.txt   9905
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Modig Berndt (Reporting) CIK: 0001643072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 17806946